Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 20 | ECE2009 | Next issue

11th European Congress of Endocrinology

Symposia

Progress in understanding and management of diabetes

ea0020s15.1 | Progress in understanding and management of diabetes | ECE2009

The metabolic syndrome is getting nervous

Romijn JA

The classical diagnostic strategy of internal medicine, including medical history, physical examination and additional diagnostic test, is unable to assess the activity of the autonomous nervous system in detail and, consequently, has resulted in negligence of the involvement of the autonomic nervous system. Nonetheless, evidence is emerging that the autonomous nervous system is involved in the pathophysiology of complex diseases. These conditions include insulin resistance, t...

ea0020s15.2 | Progress in understanding and management of diabetes | ECE2009

The metabolic memory

Ceriello Antonio

Large randomized studies have established that early intensive glycemic control reduces the risk of diabetic complications, both micro and macrovascular. However, epidemiological and prospective data support a long-term influence of early metabolic control on clinical outcomes. This phenomenon has recently been defined as ‘Metabolic Memory.’ It was first hypothesized by Brownlee (Nature 2000), and since shown by many researchers that overproduction of free radicals, ...

ea0020s15.3 | Progress in understanding and management of diabetes | ECE2009

Role of the fatty liver (NAFLD) in the pathogenesis and treatment of Type II Diabetes

Yki-Jarvinen Hannele

Several prospective studies have shown that fat accumulation in the liver due to non-alcoholic causes (NAFLD) preceeds and predicts type 2 diabetes and cardiovascular disease independent of obesity and even fat distribution, although individuals with a fatty liver tend to be more abdominally obese than those without. All components of the metabolic syndrome also correlate with liver fat independent of obesity. Both genetic and acquired factors regulate liver fat content. The h...

ea0020s15.4 | Progress in understanding and management of diabetes | ECE2009

Insulin analogues in type 2 diabetes: how far have we come?

Vaag Allan

The introduction of chemical and genetically modified short and long acting insulin molecules, as well as mixed insulin preparations, has provided novel tools to improve glycaemic regulation in patients with diabetes. Reaching the glycaemic target of an HbA1c below 7% represent a major challenge in many patients with type 2 diabetes. Different insulin preparations can be used in various different combinations with a variable number of daily injections as well as in different c...